70 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant has filed a report on an attestation to its management’s assessment of the effectiveness … trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts (Part I contains
8-K
EX-99.3
6g5abo7gedik86k9
16 May 23
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
4:24pm
424B5
4j2fl11
8 Dec 22
Prospectus supplement for primary offering
5:47pm
424B5
z361k
6 Dec 22
Prospectus supplement for primary offering
9:52pm
8-K
m1mkgrw29mew0
27 Sep 22
Regulation FD Disclosure
7:53am
8-K
EX-99.1
wrb1t6ap pvwaze
5 Aug 22
Regulation FD Disclosure
8:10am
8-K
EX-99.1
hxg5a4hm vv
4 Nov 21
Results of Operations and Financial Condition
9:01am